Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria, Muscle | 5 | 2025 | 23 | 1.400 |
Why?
|
| Muscle, Skeletal | 8 | 2025 | 308 | 0.970 |
Why?
|
| Energy Metabolism | 5 | 2024 | 181 | 0.660 |
Why?
|
| Stress, Psychological | 1 | 2025 | 641 | 0.580 |
Why?
|
| Diabetes Mellitus | 1 | 2024 | 531 | 0.580 |
Why?
|
| HIV Infections | 2 | 2025 | 2535 | 0.520 |
Why?
|
| Substance-Related Disorders | 1 | 2025 | 825 | 0.520 |
Why?
|
| Aging | 5 | 2024 | 763 | 0.510 |
Why?
|
| Informed Consent | 1 | 2016 | 34 | 0.490 |
Why?
|
| Electronic Health Records | 1 | 2016 | 99 | 0.460 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2024 | 11 | 0.370 |
Why?
|
| Mitochondria | 5 | 2024 | 516 | 0.320 |
Why?
|
| Male | 14 | 2025 | 22745 | 0.280 |
Why?
|
| Mice, Inbred mdx | 2 | 2024 | 7 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2018 | 85 | 0.250 |
Why?
|
| Aged | 8 | 2025 | 7958 | 0.240 |
Why?
|
| Muscle Fatigue | 1 | 2024 | 10 | 0.220 |
Why?
|
| Creatine | 1 | 2024 | 10 | 0.220 |
Why?
|
| Oxidation-Reduction | 1 | 2024 | 448 | 0.200 |
Why?
|
| Female | 11 | 2025 | 23980 | 0.190 |
Why?
|
| Humans | 13 | 2025 | 42113 | 0.190 |
Why?
|
| Body Mass Index | 2 | 2024 | 915 | 0.180 |
Why?
|
| Aged, 80 and over | 5 | 2025 | 2790 | 0.170 |
Why?
|
| Adenosine Triphosphate | 3 | 2024 | 205 | 0.150 |
Why?
|
| Oxidative Phosphorylation | 3 | 2024 | 56 | 0.140 |
Why?
|
| Achromobacter denitrificans | 1 | 2017 | 1 | 0.140 |
Why?
|
| Siderophores | 1 | 2018 | 14 | 0.140 |
Why?
|
| Oxygen Consumption | 3 | 2025 | 111 | 0.140 |
Why?
|
| Leukotriene B4 | 1 | 2017 | 8 | 0.140 |
Why?
|
| Macrophages, Alveolar | 1 | 2017 | 33 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 959 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2019 | 110 | 0.140 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2017 | 28 | 0.140 |
Why?
|
| Reperfusion Injury | 1 | 2018 | 57 | 0.130 |
Why?
|
| Access to Information | 1 | 2016 | 14 | 0.130 |
Why?
|
| Workflow | 1 | 2016 | 23 | 0.130 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2016 | 9 | 0.130 |
Why?
|
| Confidentiality | 1 | 2016 | 27 | 0.120 |
Why?
|
| Adult | 3 | 2025 | 13437 | 0.120 |
Why?
|
| New York | 1 | 2016 | 88 | 0.120 |
Why?
|
| Pancreas | 1 | 2016 | 45 | 0.120 |
Why?
|
| Receptor, Bradykinin B1 | 1 | 2016 | 6 | 0.120 |
Why?
|
| Melanoma, Experimental | 1 | 2016 | 13 | 0.120 |
Why?
|
| Young Adult | 2 | 2025 | 4928 | 0.120 |
Why?
|
| Lymph Nodes | 1 | 2016 | 73 | 0.120 |
Why?
|
| Middle Aged | 2 | 2024 | 11790 | 0.120 |
Why?
|
| Myocytes, Cardiac | 1 | 2018 | 173 | 0.120 |
Why?
|
| New York City | 1 | 2016 | 283 | 0.120 |
Why?
|
| Nursing Informatics | 1 | 2015 | 1 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 518 | 0.110 |
Why?
|
| Interviews as Topic | 1 | 2016 | 427 | 0.110 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2016 | 126 | 0.110 |
Why?
|
| Lung | 1 | 2017 | 484 | 0.110 |
Why?
|
| Focus Groups | 1 | 2016 | 398 | 0.110 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 222 | 0.110 |
Why?
|
| Data Collection | 1 | 2015 | 210 | 0.110 |
Why?
|
| United States | 1 | 2025 | 5068 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 175 | 0.100 |
Why?
|
| Mice, Knockout | 4 | 2018 | 1010 | 0.100 |
Why?
|
| Adolescent | 1 | 2025 | 5949 | 0.100 |
Why?
|
| Qualitative Research | 1 | 2016 | 523 | 0.100 |
Why?
|
| Mice | 6 | 2024 | 6490 | 0.100 |
Why?
|
| Inflammation | 1 | 2017 | 729 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 479 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 933 | 0.080 |
Why?
|
| Animals | 6 | 2024 | 16694 | 0.070 |
Why?
|
| Creatine Kinase, Mitochondrial Form | 1 | 2024 | 1 | 0.060 |
Why?
|
| Phosphocreatine | 1 | 2024 | 12 | 0.060 |
Why?
|
| Mobility Limitation | 1 | 2024 | 21 | 0.060 |
Why?
|
| Exercise Test | 1 | 2024 | 75 | 0.050 |
Why?
|
| Quadriceps Muscle | 1 | 2024 | 8 | 0.050 |
Why?
|
| Body Fat Distribution | 1 | 2024 | 26 | 0.050 |
Why?
|
| Intra-Abdominal Fat | 1 | 2024 | 45 | 0.050 |
Why?
|
| Frail Elderly | 1 | 2023 | 18 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2024 | 36 | 0.050 |
Why?
|
| Muscles | 1 | 2023 | 84 | 0.050 |
Why?
|
| Leg | 1 | 2023 | 19 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2024 | 180 | 0.050 |
Why?
|
| Sex Factors | 1 | 2024 | 1004 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 575 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 1554 | 0.040 |
Why?
|
| Gentisates | 1 | 2018 | 2 | 0.040 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2017 | 3 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2019 | 123 | 0.030 |
Why?
|
| alpha-Defensins | 1 | 2017 | 22 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2018 | 160 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2017 | 69 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2017 | 2111 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2017 | 83 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 254 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2018 | 193 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2018 | 282 | 0.030 |
Why?
|
| Bacterial Translocation | 1 | 2016 | 2 | 0.030 |
Why?
|
| Kallikrein-Kinin System | 1 | 2016 | 2 | 0.030 |
Why?
|
| Mitotic Index | 1 | 2016 | 10 | 0.030 |
Why?
|
| Insulin | 1 | 2018 | 255 | 0.030 |
Why?
|
| Iron | 1 | 2018 | 247 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3073 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2016 | 103 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2016 | 86 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 100 | 0.030 |
Why?
|
| Calcium | 1 | 2018 | 487 | 0.030 |
Why?
|
| Taiwan | 1 | 2015 | 21 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 50 | 0.030 |
Why?
|
| Students, Nursing | 1 | 2015 | 37 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 297 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 1617 | 0.030 |
Why?
|
| Disease Progression | 1 | 2016 | 660 | 0.020 |
Why?
|
| Exercise | 1 | 2018 | 674 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 1804 | 0.020 |
Why?
|
| Rats | 1 | 2018 | 3701 | 0.020 |
Why?
|